ECP 2022 Final Programme

Tuesday, 6 Sept 56 Scientific Programme a Tuesday 015 11:40–11:50 Filamin-A expression in triple negative breast cancer (TNBC) and its clinical significance Abderrahman Ouban, Saudi Arabia 016 11:50–12:00 Nullisomy of chromosome 17 in invasive breast cancer: characterisation of a rare and puzzling genomic event Magali Lacroix-Triki, France A. Valent, A. Fitouri, F. Delalande, N. Joyon, P. Michenet OFP-11 Oral Free Paper Session 08:30–12:00 Osaka/Samarkand Joint Oral Free Paper Session IT & Other Topics (Electron Microscopy / Cardiovas- cular Pathology) Chairs: Jason Hornick, USA Sabina Berezowska, Switzerland Heike Göbel, Germany 001 08:30–08:40 Epidermolysis bullosa: an electron microscopy study of 6 cases Adelina-Maria Cohn, Romania C. Salavastru, M. Gherghiceanu 002 08:40–08:50 Clinico-pathologic correlation in cardiac amyloidosis: is there a substrate for the echocardiographic “relative apical sparing” sign? Monica De Gaspari, Italy G. Sinigiani, S. Rizzo, M. Perazzolo Marra, M. Della Barbera, D. Mele, C. Basso, A. Cipriani 003 08:50–09:00 Acute Myocarditis in COVID-19 era: pre-pandemic and pandemic periods compared Mattia Riefolo, Italy M. Sabatino, C. Baldovini, C. Marcelli, L. Potena, O. Leone 004 09:00–09:10 From conventional congenital cardiac surgery to molecular cardiac surgery: between darkness and light. New para- digms for investigations and treatments during pregnancy Athos Capuani, Italy 005 09:10–09:20 Reporting guidelines for pathology AI research – a review Clare Mcgenity, United Kingdom D. Treanor 006 09:20–09:30 A holistic evaluation of three-dimensional biomarker expression and genetic alterations in non-small cell lung cancer using tissue clearing technology Lei-Chi Wang, Taiwan Y. Hsieh, Y. Hung, Y. Chen, Y. Lin, Y. Lin, T. Chou 008 10:30–10:40 CoNIC Challenge: large scale assessment of automated methods for identification and counting of Colon Nuclei Simon Graham, United Kingdom Q. Vu, M. Jahanifar, D. Snead, S. Raza, F. Minhas, N. Rajpoot 009 10:40–10:50 Quantification of metabolic heterogeneity across multiple imaging modalities Esther Smeets, The Netherlands M. Trajkovic-Arsic, D. Geijs, M. van Zanten, L. Brosens, B. Feuerecker, M. Gotthardt, J. Siveke, R. Braren, F. Ciompi, E. Aarntzen 010 10:50–11:00 Artificial Intelligence as a potential tool for pathologists to evaluate lymphocyte infiltration in melanoma Carlos E De Andrea, Spain A. Romano Martínez Martínez, D. Jiménez- Sánchez, J. Echeveste, S. Martín Algarra, M. Lozano Escario 011 11:00–11:10 Artificial intelligence-guided spatial transcriptomics in high grade serous carcinoma: toward image-analysis based precision oncology Anna Laury, Finland S. Zheng, O. Youssef, J. Tang, O. Carpen 012 11:10–11:20 Development of trial quality assurance program for digital pathology of the Korean Society of Pathologists Yosep Chong, Republic of Korea J. Bae, D. Kang, K. Kim, H. Han